Distribution

Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has unveiled a major development with plans to raise Rs 2,475 crore ($339 million) in equity capital from Advent International, a prominent private equity investor. This strategic move is part of a merger initiative that will also integrate Keimed Private Limited, India’s leading wholesale pharmaceutical distributor, within the next two years. The merger deal entails Advent International acquiring a 12.1% stake in the merged entity, while Apollo HealthCo and Keimed will hold 59.2% and 25.7% stakes, respectively. The combined entity is valued at an impressive enterprise value of Rs 22,481 crores ($3 billion). Dr. Prathap C Reddy, Chairman of Apollo Hospitals Group, emphasized the mission to provide high-quality healthcare to all Indians at an affordable cost. He highlighted the significant outreach achieved by Apollo 24/7, which has positively impacted over 33 million Indians. Dr. Reddy expressed confidence that with Advent’s investment and the merger with Keimed, the combined entity will emerge as one of the leading retail health companies in India. The integration is poised to deliver substantial industry benefits and capitalize on potential business synergies. With a pan-India presence, the merged entity aims to become a frontrunner in the retail health sector. Shobana Kamineni, Executive Vice Chairperson of Apollo Hospitals, underscored the enhanced accessibility to genuine medicines for 1.4 billion Indians within 24 minutes to 24 hours, 7 days a week, facilitated by the merged supply chain. Suneeta Reddy, Managing Director of Apollo Hospitals, described the merger with Keimed as a pivotal step towards building a comprehensive supply chain. She outlined the revenue projections and emphasized the collaborative strengths that will drive exponential value for Apollo Hospitals and its shareholders. Advent International sees this partnership as an opportunity to invest in India’s rapidly growing healthcare sector and contribute creatively to value creation. The merger positions Keimed at an enterprise value of Rs 8,003 crores, with Keimed shareholders holding a maximum of 25.7% stake in the combined entity, while Apollo Hospitals remains the largest controlling shareholder with at least 59.2% stake. The merger is subject to further corporate approvals.